Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000868567 | SCV001009910 | benign | Long QT syndrome | 2024-01-21 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001655623 | SCV001870183 | likely benign | not provided | 2021-02-02 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002319997 | SCV002607609 | likely benign | Cardiovascular phenotype | 2020-09-01 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Fulgent Genetics, |
RCV002495284 | SCV002801048 | likely benign | Long QT syndrome 13; Familial hyperaldosteronism type III | 2022-01-04 | criteria provided, single submitter | clinical testing |